In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 307 for your search:
Cancer Type/Condition:  Lung cancer, small cell
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 60 to 80
Sponsor: Other
Protocol IDs: PROLOG, NCT00675168
2.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2612-3681, NCT00724581
3.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18
Sponsor: Other
Protocol IDs: P080204, IDRCB 2008-A01386-49, NCT00925444
4.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 11021, NCT01381627
5.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: VMT-SPiN_01, NCT01389154
6.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PAN-001, NCT01658280
7.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Haema CBF SCLC UK/AS 01, NCT00168896
8.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
9.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201106336, NCT01446874
10.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: GLiang, NCT01498055
11.

Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: R05-0076, NCT00207298
12.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005P000376, NCT00300495
13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000531141, CRUK-LUNGSTAR, EU-20649, ISRCTN56306957, EUDRACT-2005-005821-71, UCL-BRD/05/129, MREC-06-MRE10-28, CTA-20363-0215-001, CTAAC-C1312-A5335, CTAAC-C1312-A12462, NCT00433498
14.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000531709, CHNT-CONVERT, CHNT-CTAAC-CONVERT-C17052/A815, EU-20669, CHNT-CTAAC-CONVERT-C17052/A8152, NCT00433563
15.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000561532, WCTU-FRAGMATIC, Velindre-FRAGMATIC, WCTU-02, EU-20753, PFIZER-WCTU-02, EUDRACT-2005-002438-37, ISRCTN80812769, NCT00519805
16.

Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: STAD-1, 2006-003995-36, NCT00526396
17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-30610, CALGB 30610, RTOG 0538, NCT00632853
18.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ELCWP 01994, NCT00658580
19.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT number 2007-006033-14, NCT00717938
20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DOLG7, NCT00812266
21.

Phase: Phase III
Type: Treatment
Status: Active
Age: 19 to 80
Sponsor: Other
Protocol IDs: CSCLC-0810, NCT00826644
22.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 25387, 1 R01 HL95109-01, NCT00876915
23.

Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AMI-2008-01, NCT00882609
24.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHU-0064, NCT01053624
25.

Phase: Phase III
Type: Behavioral study
Status: Active
Age: 21 to 80
Sponsor: NCI, Other
Protocol IDs: 00018255, 1R01CA138624-01A1, NCT01068210
1     
New Search